Pathophysiology of acute exacerbations of COPD

Chronic Obstructive Pulmonary Disease Exacerbations

Volumn , Issue , 2008, Pages 75-88

  Parker, Chris M ^a   O’Donnell, Denis E ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 67650040443     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (66)

1. O’Donnell DE, Aaron S, Bourbeau J, et al. Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease-2007 update. Can Respir J 2007; 14(suppl B): 5B-32B.
2. Vincken W, van Noord JA, Greefhorfst APM, et al. Improved health outcomes in patients with COPD during 1 yr’s treatment with tiotropium. Eur Respir J 2002; 19: 209-216.
3. Poole PJ, Black PN. Oral mucolytic drugs for exacerbations of chronic obstructive pulmonary disease: systematic review. BMJ 2001; 322: 1271-1274.
4. O’Donnell DE, Parker CM. COPD Exacerbations. 3: Pathophysiology. Thorax 2006; 61: 354-361.
5. Niewoehner DE, Collins D, Erbland ML. Relation of FEV1 to clinical outcomes during exacerbations of chronic obstructive pulmonary disease. AmJ Respir Crit CareMed 2000; 161: 1201-1205.
6. Aaron SD, Vandemheen KJ, Hebert P, et al. Outpatient oral prednisone after emergency treatment of chronic obstructive pulmonary disease. N Engl J Med 2003; 348: 2618-2625.
7. Sachs AP, Koeter GH, Groenier KH, et al. Changes in symptoms, peak expiratory flow, and sputum flora during treatment with antibiotics of exacerbations in patients with chronic obstructive pulmonary disease in general practice. Thorax 1995; 50: 758-763.
8. Davies L, Angus RM, Calverley PMA. Oral corticosteroids in patients admitted to hospital with exacerbations of chronic obstructive pulmonary disease: a prospective randomized controlled trial. Lancet 1999; 354: 456-460.
9. Bhowmik A, Seemungal TAR, Sapsford RJ et al. Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations. Thorax 2000; 55: 114-120.
10. Seemungal TAR, Donaldson GC, Bhowmik A, et al. Time course of recovery of exacerbations in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999; 161: 1608-1613.
11. Parker CM, Voduc N, Aaron SD, et al. Physiological changes during symptom recovery from moderate exacerbations of COPD. Eur Respir J 2005; 26: 420-428.
12. Rodriguez-Roisin R. Towards a consensus definition for COPD exacerbations. Chest 2000; 117 (suppl. 2): 398S-401S.
13. Stevenson NJ, Walker PP, Costello RW, et al. Lung mechanics and dyspnea during exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005; 172: 1510-1516.
14. Johnson MK, Birch M, Carter R, et al. Measurement of physiological recovery from exacerbation of chronic obstructive pulmonary disease using within-breath forced oscillometry. Thorax 2007; 62: 299-306.
15. Howard P. A long-term follow-up of respiratory symptoms and ventilatory function in a group of working men. Br J Industr Med 1970; 27: 326-333.
16. Bates D. The fate of the chronic bronchitic: a report of the 10-year follow-up in the Canadian Department of Veteran’s Affairs coordinated study of chronic bronchitis. Am Rev Respir Dis 1973; 108: 1043-1065.
17. Kanner RE, Renzetti AD, Klauber MR, et al. Variables associated with changes in spirometry in patients with obstructive lung disease. Am J Med 1979; 67: 44-50.
18. Kanner RE, Anthonisen NR, Connett JE. Lower respiratory illnesses promote FEV1 decline in current smokers but not ex-smokers with mild chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 164: 358-364.
19. Donaldson GC, Seemungal TAR, Bhowmik A, et al. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax 2002; 57: 847-852.
20. O’Donnell DE, Laveneziana P. Physiology and consequences of lung hyperinflation in COPD. Eur Respir Rev 2006; 15: 61-67.
21. Pare PD, Brooks LA, Bates J. Exponential analysis of the lung pressure-volume curve as a predictor of pulmonary emphysema. Am Rev Respir Dis 1982; 126: 54-61.
22. Haluszka J, Chartrand DA, Grassino AE, et al. Intrinsic PEEP and arterial pCO2 in stable patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 1990; 141: 1194-1197.
23. Sinderby C, Spahija J, Beck J, et al. Diaphragm activation during exercise in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 163: 1637-1641.
24. O’Donnell DE. Exercise limitation and clinical exercise testing in chronic obstructive pulmonary disease. In: Zeballos RJ, Weisman IM, eds. Clinical Exercise Testing: Progress in Respiratory Research. Basel, Switzerland: Karger Series, 2002; 32: 138-158.
25. Yan S, Kaminski D, Sliwinski P. Reliability of inspiratory capacity for estimating end-expiratory lung-volume changes during exercise in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1997; 156: 55-59.
26. Calverley PMA. Respiratory failure in chronic obstructive pulmonary disease. Eur Respir J; 2003: 22, 26-30.
27. Barbera JA, Roca J, Ferrer A, et al. Mechanisms of worsening gas exchange during acute exacerbations of chronic obstructive pulmonary disease. Eur Respir J 1997; 10: 1285-1291.
28. O’Donnell DE, D’Arsigny C, Fitzpatrick M, et al. Exercise hypercapnia in advanced chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2002; 166: 663-668.
29. Aubier M, Murciano D, Milic-Emili J, et al. Effects of the administration of O2 on ventilation and blood gases in patients with chronic obstructive pulmonary disease during acute respiratory failure. Am Rev Respir Dis 1980; 122: 747-754.
30. Hanson CW, Marshall BE, Frasch HF, et al. Causes of hypercarbia with oxygen therapy in patients with chronic obstructive pulmonary disease. Crit Care Med 1996; 24: 23-28.
31. Robinson TD, Freiberg DB, Regnis JA, et al. The role of hypoventilation and ventilationperfusion redistribution in oxygen-induced hypercapnia during acute exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000; 161: 1524-1529.
32. Seneff MG, Wagner DP, Wagner RP, et al. Hospital and 1-year survival of patients admitted to intensive care units with acute exacerbations of chronic obstructive pulmonary disease. JAMA 1995; 274: 1852-1857.
33. Connors AFJ, Dawson NV, Thomas C, et al. Outcomes following acute exacerbations of severe chronic obstructive lung disease. The SUPPORT investigators. Am J Respir Crit Care Med 1996; 154: 959-967.
34. Khoukaz G, Gross NJ. Effects of salmeterol on arterial blood gases in patients with stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999; 160: 1028-1030.
35. Polverino E, Gomez FP, Manrique H, et al. Gas exchange response to short-acting b2-agonists in chronic obstructive pulmonary disease severe exacerbations. Am J Respir Crit Care Med 2007; 176: 350-355.
36. Ranieri VM, Dambrosio M, Brienza N. Intrinsic PEEP and cardiopulmonary interaction in patients with COPD and acute ventilatory failure. Eur Respir J 1996; 9: 1283-1292.
37. Dhainaut JF, Brunet F. Phasic changes of right ventricular ejection fraction in patients with acute exacerbation of chronic obstructive pulmonary disease. Intensive Care Med 1987; 12: 214-215.
38. Settle HP, Engel PJ, Fowler NO. Echocardiographic study of the paradoxical arterial pulse in chronic obstructive pulmonary disease. Circulation 1980; 62: 1297-1307.
39. Jardin F, Gueret P, Prost JF, et al. Two-dimensional echocardiographic assessment of left ventricular function in chronic obstructive pulmonary disease. Am Rev Respir Dis 1984; 129: 135-142.
40. Mahler DA, Brent BN, Loke J, et al. Right ventricular performance and central circulatory hemodynamics during upright exercise in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 1984; 130: 722-729.
41. Lemaire F, Tebul JL, Cinotti L, et al. Acute left ventricular dysfunction during unsuccessful weaning from mechanical ventilation. Anaesthesiology 1988; 69: 171-179.
42. Marangoni S, Scalvini S, Schena M, et al. Right ventricular diastolic dysfunction in chronic obstructive lung disease. Eur Respir J; 1992: 5, 438-443.
43. Magee F, Wright JL, Wiggs BR, et al. Pulmonary vascular structures and function in chronic obstructive pulmonary disease. Thorax 1988; 43: 183-189.
44. Agusti AGN, Barbera JA, Roca J, et al. Hypoxemic pulmonary vasoconstriction and gas exchange during exercise in chronic obstructive pulmonary disease. Chest 1990; 97: 268-275.
45. Whittenberger JL, McGregor M, Berglund E. Influence of state of inflation of the lung on pulmonary vascular resistance. J Appl Physiol 1960; 15: 878-882.
46. Matthay RA, Berger HJ, Davies RA, et al. Right and left ventricular exercise performance in chronic obstructive pulmonary disease: radionucleotide assessment. Ann Intern Med 1980; 93: 234-239.
47. Oswald-Mammosser M, Apprill M, Bachez P, et al. Pulmonary hemodynamics in chronic obstructive pulmonary disease of the emphysematous type. Respiration 1991; 58304-58310.
48. Nakhjaven FK, Palmer WH, McGregor M. Influence of respiration on venous return in pulmonary emphysema. Circulation 1966; 33: 8-16.
49. Brookhart JM, Boyd TE. Local differences in intrathoracic pressure and their relation to cardiac filling pressure in the dog. Am J Physiol 1947; 148: 434-444.
50. Pinsky MR. Determinants of pulmonary artery flow variation during respiration. J Appl Physiol 1984; 56: 1237-1245.
51. Dambrosio M, Cinnella G, Brienza N, et al. Effects of positive end-expiratory pressure on right ventricular function in COPD patients during acute ventilatory failure. Intensive Care Med 1996; 22: 923-932.
52. Vizza CD, Lynch JP, Ochoa LL, et al. Right and left ventricular dysfunction in patients with severe pulmonary disease. Chest 1998; 113: 576-583.
53. Richard C, Tebul JL, Archambaud F, et al. Left ventricular function during weaning of patients with chronic obstructive pulmonary disease. Intensive Care Med 1994; 20: 181-186.
54. Pride NB, Macklem PT. Lung mechanics in disease. In: AP Fishman, ed. Handbook of Physiology, section 3, volume III, part 2: The Respiratory System. Bethesda, MD: American Physiological Society, 1986: 659-692.
55. O’Donnell DE, Webb KA. Exercise. In: Calverley PMA, MacNee W, Pride NB, et al., eds. Chronic Obstructive Pulmonary Disease, 2nd ed. London: Arnold, 2003: 243-269.
56. Orozco-Levi M. Structure and function of the respiratory muscles in patients with COPD: impairment or adaptation? Eur Respir J 2003; 22(suppl 46): 41s-51s.
57. Chen Z, Eldridge FL, Wagner PG. Respiratory-associated thalamic activity is related to the level of respiratory drive. Resp Physiol 1992; 90: 99-113.
58. De Troyer A, Leeper JB, McKenzie DK, et al. Neural drive to the diaphragm in patients with severe COPD. Am J Respir Crit Care Med 1997; 155: 1335-1340.
59. Sinderby C, Spahija J, Beck J, et al. Diaphragm activation during exercise in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 163: 1637-1641.
60. O’Donnell DE, Chau LKL, Bertley JC, et al. Qualitative aspects of exertional breathlessness in chronic airflow limitation: pathophysiologic mechanisms. Am J Respir Crit Care Med 1997; 155: 109-115.
61. Lougheed MD, Webb K, O’Donnell DE. Breathlessness during induced hyperinflation in asthma: role of the inspiratory threshold load. Am J Respir Crit Care Med 1995; 152: 911-920.
62. Lougheed MD, Fisher T, O’Donnell DE. Dynamic hyperinflation during bronchoconstriction in asthma: implications for symptom perception. Chest 2006; 130: 1072-1081.
63. Evans KC, Banzett RB, Adams L, et al. BOLD fMRI identifies limbic, paralimbic, and cerebellar activation during air hunger. J Neurophysiol 2002; 88: 1500-1511.
64. Liotti M, Brannan S, Egan G, et al. Brain responses associated with consciousness of breathlessness (air hunger). Proc Natl Acad Sci USA 2001; 98: 2035-2040.
65. Peiffer C, Poline J, Thivard L, et al. Neural substrates for the perception of acutely induced dyspnea. Am J Respir Crit Care Med 2001; 163: 951-957.
66. Banzett RB, Mulnier HE, Murphy K, et al. Breathlessness in humans activates insular cortex. Neuroreport 2000; 11: 2117-2120.